HBV-TCR T Cells (LioCyx-M)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HBV-TCR T Cells (LioCyx-M), covering 2025-03-10 to 2025-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC [Phase 2]